Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00493974 · ClinicalTrials.gov registry record · Phase 3
Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study)
A Phase 3 study, sponsored by University of Minnesota.
- Terminated
- Registry status
- Phase 3
- Development phase
- 119
- Enrollment target
NCT00493974 is a Phase 3 study that was terminated before completion, run by University of Minnesota. The registered enrollment target is 119 participants.
The verdict
NCT00493974, a Phase 3 study, was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 119 participants
- Enrollment target
Study Summary
Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is caused by cigarette smoking or by breathing in other lung irritants, including pollution, dust, or chemicals. The purpose of this study is to evaluate the effectiveness of zileuton, a medication that is used to control asthma symptoms, at reducing the length of a hospital stay for adults who are hospitalized for a COPD exacerbation, or worsening of COPD symptoms.
Interventions
- DRUG Placebo
- DRUG Zileuton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00493974
The ClinicalTrials.gov registry entry for NCT00493974 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00493974 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00493974 about?
NCT00493974 is a clinical study titled "Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study)". Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is caused by cigarette smoking or by breathing in other lung irritants, including pollution, dust, or chemicals. The purpose of this study is to evaluate the effectiveness of zileuton, a medication that is used to control ...
What is the current status of trial NCT00493974?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 119 participants. The study started on 2007-03. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00493974?
The interventions under investigation include: Placebo (DRUG), Zileuton (DRUG).
Who is sponsoring clinical trial NCT00493974?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.